Serán BioScience announced the completion of two of the three new buildings and commencement of construction of the third facility for its new 100,000-square-foot commercial manufacturing campus in Bend, Oregon.
The new campus will encompass a 50,000-square-foot manufacturing facility, complemented by an adjacent 50,000-square-foot space dedicated to specialized packaging and supply chain operations.
Specializing in spray drying, particle engineering, and advanced drug formulation, the U.S. facility is built to produce commercial-scale, non-sterile solid dose products.
Adjacent to the new plant, Serán has completed two newly constructed warehouse and light manufacturing buildings totaling 50,000 square feet. These facilities support advanced materials management, packaging, labeling, and other critical logistics functions essential for seamless scale-up and supply chain reliability.
Located just minutes from Serán’s existing 90,000-square-foot clinical development and manufacturing campus, the new commercial site will integrate with the company’s established clinical operations. The Bend campus houses more than 190 professionals and features 10 specialized buildings equipped with technologies including nano milling, micronization, dry and wet granulation, spray-dried dispersions, twin-screw melt extrusion, and more. These capabilities span the full spectrum of oral solid dose development, from early-phase formulation through clinical trial manufacturing, packaging, and labeling.
